Edition:
United Kingdom

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

13.47USD
18 May 2018
Change (% chg)

$0.07 (+0.52%)
Prev Close
$13.40
Open
$13.90
Day's High
$14.45
Day's Low
$13.47
Volume
5,131
Avg. Vol
7,221
52-wk High
$24.70
52-wk Low
$10.01

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $470.69
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

  NITE.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -0.50 -- --
ROI: -- 1.57 14.38
ROE: -- 2.43 16.07

BRIEF-Nightstar Therapeutics Starts Star Phase 3 Registrational Trial For Nsr-Rep1 In Choroideremia

* NIGHTSTAR THERAPEUTICS ANNOUNCES INITIATION OF STAR PHASE 3 REGISTRATIONAL TRIAL FOR NSR-REP1 IN CHOROIDEREMIA

05 Mar 2018

Earnings vs. Estimates